"10.1371_journal.pone.0149094","plos one","2016-03-07T00:00:00Z","Kerstin Hellwig; Lie H Chen; Frank Z Stancyzk; Annette M Langer-Gould","St. Josef University Hospital, Bochum, Neuroimmunological Ward and Outpatient Clinic, Bochum, Germany; Kaiser Permanente Southern California, Department of Research & Evaluation, Pasadena, California, United States of America; University of Southern California, Keck School of Medicine, Los Angeles, California, United States of America; Kaiser Permanente, Southern California Los Angeles Medical Center, Neurology Department, Los Angeles, California, United States of America","Conceived and designed the experiments: KH ALG. Performed the experiments: KH ALG. Analyzed the data: KH LC FS ALG. Contributed reagents/materials/analysis tools: KH LC FS ALG. Wrote the paper: KH LC FS ALG.","Dr. Hellwig has been supported by the German Research Council Deutsche Forschungsgemeinshaft and has received speaker honoraria from Biogen Idec, Teva Sanofi Aventis, Novartis, Bayer Healthcare and Merck Serono. Dr. Langer-Gould is site principal investigator for two industry-sponsored phase 3 clinical trials (Biogen-Idec, Hoffman-LaRoche) and was site PI on one industry-sponsored observation study (Biogen-Idec). She received grant support from the National Institutes of Health, National Institute of Neurological Disorders and Stroke, and the National Multiple Sclerosis Society. Lie Chen, Christopher Schroeder and Frank Stancyzk have declared that no competing interests exist. These competing interests do not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2016","03","Kerstin Hellwig","KH",4,FALSE,2,2,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
